Profund Advisors’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-3,478
Closed -$256K 1431
2021
Q4
$256K Sell
3,478
-311
-8% -$25.6K 0.01% 1090
2021
Q3
$345K Buy
+3,789
New +$322K 0.01% 845

Other funds holding ASTH

Profund Advisors's ASTH Position: Q1 2022 in Review

Profund Advisors sold out of Astrana Health (ASTH) in Q1 2022, closing a stake of 3,478 shares — an estimated $256K sold.

Profund Advisors first reported a position in ASTH in Q3 2021 and held it in 2 quarters. The position peaked at $345K in Q3 2021. 139 funds tracked by Wall St. Rank hold ASTH as of Q1 2022.

  • Profund Advisors reported no remaining Astrana Health position as of Q1 2022 after selling out during the quarter.
  • Profund Advisors sold 3,478 Astrana Health shares in Q1 2022, an estimated $256K.
  • Profund Advisors first reported a position in Astrana Health in Q3 2021 and held it in 2 quarters.
  • Profund Advisors's Astrana Health position peaked at $345K in Q3 2021.
  • 139 funds tracked by Wall St. Rank held Astrana Health as of Q1 2022.

Based on Profund Advisors's 13F filing for Q1 2022, filed 10 May 2022.